0001237899-13-000021.txt : 20130402
0001237899-13-000021.hdr.sgml : 20130402
20130402092353
ACCESSION NUMBER: 0001237899-13-000021
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130401
FILED AS OF DATE: 20130402
DATE AS OF CHANGE: 20130402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDSTEIN JOSEPH L
CENTRAL INDEX KEY: 0001225474
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 13733511
MAIL ADDRESS:
STREET 1: DEPT OF PHARMACOLOGY K5 YUVER OF TEXAS
STREET 2: 5323 HARRY HINES BLVD
CITY: DALLAS
STATE: TX
ZIP: 75390
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2013-04-01
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001225474
GOLDSTEIN JOSEPH L
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
Common Stock
2013-04-01
4
M
0
5000.0
24.41
A
5000
D
Common Stock
2013-04-01
4
S
0
5000.0
180.0
D
0
D
Non-Qualified Stock Option (right to buy)
24.41
2013-04-01
4
M
0
5000.0
D
2020-01-04
Common Stock
5000
0
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
/s/**Joseph L. Goldstein
2013-04-01